aan het Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180(1) in press.
aan het Rot M, Charney DS, Mathew SJ (2008) Intravenous ketamine for treatment-resistant major depressive disorder. Primary Psychiatry 15(4): 39-47.
LINK
Coplan JD, Mathew SJ, et al: Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma. Psychiatry Research: Neuroimaging 2006; 147 (1): 27-39.
LINK
Coplan JD, Altemus MA, Mathew SJ, Smith ELP, Scharf B, Coplan PM, Kral JS, Gorman JM, Owens MJ, Nemeroff CB, Rosenblum LA: Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demand. CNS Spectrums 2005; 10: 530-536.
LINK
Coplan JD, Mathew SJ, Smith ELP, Trost RC, Scharf BA, Martinez J, Gorman JM, Monn JA, Schoepp DD, Rosenblum LA: Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function. CNS Spectrums 2001; 6 (7): 607-617.
LINK
Coplan JD, Smith ELP, Altemus M, Mathew SJ, Perera T, Kral JG, Gorman JM, Owens MJ, Nemeroff CB, Rosenblum LA: Maternal-infant response to variable foraging demand in nonhuman primates: effects of timing of stressor on cerebrospinal fluid corticotropin-releasing factor and circulating glucocorticoid concentrations. Ann NY Acad Sci 2006, 1071: 525-533.
LINK
Haglund MEM, aan het Rot M, Cooper NS, Nestadt PS, Muller D, Soutwick SM, Charney DS (2009) Resilience in the third year of medical school: a prospective study of the effects of stressful events occurring during clinical rotations on student well-being. Acad Med 84(2) in press.
Mathew SJ, Manji HK, Charney DS: Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92. Epub 2008 Jan 2. Review. Erratum in: Neuropsychopharmacology. 2008 Aug;33(9):2300.
LINK
Mathew SJ, Yudofsky SC, McCullough LB, Teasdale TA, Jankovic J: Attitudes towards neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorder: results of a national survey of neurologists and psychiatrists. J. Neuropsychiatry Clin Neuroscience. 1999; 11: 259-267.
LINK
Mathew SJ, Coplan JD, Smith ELP, Schoepp DD, Rosenblum LA, Gorman JM: Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disorders. CNS Spectrums 2001; 6 (7): 555-564.
LINK
Mathew SJ, Coplan JD, Gorman JM: Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry. 2001; 158 (10): 1558-1567.
LINK
Mathew SJ, Coplan JD, Perko K, Goetz RR, de la Nuez M, Hollander E, Liebowitz MR, Fallon BA: Neuroendocrine predictors of response to intravenous clomipramine for refractory obsessive-compulsive disorder. Depression and Anxiety 2001; 14:199-208.
LINK
Mathew SJ, Coplan JD, Gorman JM: Management of treatment-refractory panic disorder. Psychopharmacology Bulletin 2001; 35: 97-110.
LINK
Mathew SJ, Coplan JD, Smith ELP, Scharf BA, Owens MJ, Nemeroff CB, Mann JJ, Gorman JM, Rosenblum LA: Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing. Stress 2002; 5(3): 185-193.
LINK
Mathew SJ, Coplan JD, Goetz RR, Feder A, Greenwald S, Dahl RE, Ryan ND, Mann JJ, Weissman MM: Differentiating depressed adolescent twenty-four hour cortisol secretion in light of their adult clinical outcome. Neuropsychopharmacology 2003; 28: 1336-1343.
LINK
Mathew SJ, Shungu DC, Mao X, Smith ELP, Perera GM, Kegeles LS, Perera T, Lisanby SH, Rosenblum LA, Gorman JM, Coplan JD: A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. Biol Psychiatry 2003; 54: 727-735.
LINK
Mathew SJ, Mao X, Coplan JD, Smith ELP, Sackeim HA, Gorman JM, Shungu DC: Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry 2004; 161: 1119-1121.
LINK
Mathew SJ, Amiel JA, Coplan JD, Fitterling H, Sackeim HA, Gorman JM: Riluzole in generalized anxiety disorder. Am J Psychiatry 2005; 162: 2379-2381.
LINK
Mathew SJ, Amiel JA, Sackeim HA: Electroconvulsive therapy for treatment resistant depression. Primary Psychiatry 2005; 12: 52-56.
LINK
Mathew SJ, Price RB, Mao X, Smith ELP, Coplan JD, Charney DS, Shungu DC: Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety Disorder. Biol Psychiatry 2008; 63 (9): 891-898
LINK
Mathew SJ, Manji HK, Charney DS: Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008; 33 (9): 2080-2092
LINK
Mathew SJ, Price RB, Charney DS: Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics, Am J Med Genetics Part C: Seminars in Med Genetics, 148C: 89-98.
LINK
Mathew SJ, Garakani A, Reinhard JF, Oshana S, Donahue S: A 28-day, open-label study of the short-term tolerability of a non-azapirone selective 1A agonist in adults with generalized anxiety disorder. Clin Therapeutics, in press.
Mathew SJ, Mao X, Keegan KA, Levine SM, Smith ELP, Otcheretko V, Coplan JD, Shungu DC: Elevated Ventricular Lactate in Chronic Fatigue Syndrome: A Proton Magnetic Resonance Spectroscopic Imaging Study. NMR Biomed, in press.
LINK
Neria Y, Gross R, Olfson M, Gameroff MJ, Wickramaratne P, Das A, Pilowsky D, Feder A, Blanco C, Marshall RD, Lantigua R, Shea S, Weissman MM. Posttraumatic stress disorder in primary care one year after the 9/11 attacks. Gen Hosp Psychiatry. 2006 May-Jun;28(3):213-22.
LINK
Olfson M, Das AK, Gameroff MJ, Pilowsky D, Feder A, Gross R, Lantigua R, Shea S, Weissman MM. Bipolar depression in a low-income primary care clinic. Am J Psychiatry. 2005 Nov;162(11):2146-51.
LINK
Ozbay F, Fitterling H, Charney D, Southwick S: Social support and resilience to stress across the life span: a neurobiologic framework. Curr Psychiatry Rep. 2008 Aug;10(4):304-10.
LINK
Ozbay F, Wigg KG, Turanli ET, Asherson P, Yazgan Y, Sandor P, Barr CL: Analysis of the dopamine beta hydroxylase gene in Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):673-7.
LINK
Pilowsky DJ, Olfson M, Gameroff MJ, Wickramaratne P, Blanco C, Feder A, Gross R, Neria Y, Weissman MM. Panic disorder and suicidal ideation in primary care. Depress Anxiety. 2006;23(1):11-6.
LINK
Rickels K, Mathew SJ, Banov MD, Zimbroff DL, Oshana S, Parsons EC, Kauffman M, Iyer GR, Donahue SR, Reinhard JF: Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2008; 28 (2), 235-9.
LINK
Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ, Rasmussen A, Gelernter J: Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):387-93.
LINK
